Literature DB >> 1331487

Experimental studies on the changes of adrenergic receptors in rat liver with acute injury and in endotoxemia.

Y P Rao1, S B Li.   

Abstract

Previous studies suggested that hepatic alpha and beta adrenergic receptors is stable and it is in dynamic equilibrium under normal conditions. However, at a pathological condition these receptors may be changed. We studied the changes of adrenergic receptors in the rat liver with acute injury and in endotoxemia by light microscopic autoradiography. Our experimental results reveal that in the liver of rats with acute injury and in endotoxemia there were changes in varying degrees of alpha and beta adrenoceptors. Moreover, the changes were not uniform in various structures of the rat liver. Glucagon can keep adrenergic receptors stable on hepatic cells and muscular cells of blood vessels in the rat liver. Our experiment provides evidence for clinical use of adrenoceptor antagonists in the treatment of acute and chronic liver disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331487     DOI: 10.1007/bf02887793

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  4 in total

1.  Early, reversible plasma membrane injury in galactosamine-induced liver cell death.

Authors:  S K El-Mofty; M C Scrutton; A Serroni; C Nicolini; J L Farber
Journal:  Am J Pathol       Date:  1975-06       Impact factor: 4.307

Review 2.  The role of protein kinase C in cell surface signal transduction and tumour promotion.

Authors:  Y Nishizuka
Journal:  Nature       Date:  1984 Apr 19-25       Impact factor: 49.962

3.  The hepatic alpha 1-adrenergic receptor.

Authors:  M Goodhardt; N Ferry; M Aggerbeck; J Hanoune
Journal:  Biochem Pharmacol       Date:  1984-03-15       Impact factor: 5.858

4.  Alpha-adrenergically mediated changes in membrane lipid fluidity and Ca2/ binding in isolated rat liver plasma membranes.

Authors:  G M Burgess; F Giraud; J Poggioli; M Claret
Journal:  Biochim Biophys Acta       Date:  1983-06-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.